Guardian Pharmacy Services (NYSE:GRDN) Reaches New 12-Month High – Still a Buy?

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) reached a new 52-week high during trading on Tuesday . The stock traded as high as $47.04 and last traded at $47.0070, with a volume of 80098 shares trading hands. The stock had previously closed at $46.49.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Weiss Ratings raised shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Bank of America lifted their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Wall Street Zen upgraded Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Finally, Oppenheimer increased their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $43.83.

Guardian Pharmacy Services Price Performance

The company’s 50-day moving average is $40.03 and its two-hundred day moving average is $38.56. The firm has a market cap of $2.37 billion, a P/E ratio of 46.43, a PEG ratio of 2.26 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last issued its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The company had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million. On average, analysts expect that Guardian Pharmacy Services, Inc. will post 1.19 EPS for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently added to or reduced their stakes in GRDN. TimesSquare Capital Management LLC boosted its holdings in shares of Guardian Pharmacy Services by 21.9% in the 4th quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock valued at $31,538,000 after purchasing an additional 187,963 shares in the last quarter. Jennison Associates LLC raised its holdings in shares of Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock worth $30,986,000 after buying an additional 706,823 shares in the last quarter. Braun Stacey Associates Inc. acquired a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth $14,234,000. Sei Investments Co. lifted its position in shares of Guardian Pharmacy Services by 40.5% during the 1st quarter. Sei Investments Co. now owns 358,181 shares of the company’s stock worth $13,489,000 after buying an additional 103,177 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Guardian Pharmacy Services by 200.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock worth $7,855,000 after buying an additional 139,070 shares during the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.